Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of “Moderate Buy” by Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $38.71.

A number of equities research analysts have recently issued reports on SGRY shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research note on Friday, October 4th. Benchmark restated a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a research report on Monday, August 26th. Macquarie reiterated an “outperform” rating and issued a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. Royal Bank of Canada dropped their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a report on Wednesday. Finally, Citigroup decreased their price target on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. FMR LLC grew its holdings in shares of Surgery Partners by 3.1% during the 3rd quarter. FMR LLC now owns 18,311,867 shares of the company’s stock worth $590,375,000 after acquiring an additional 546,869 shares during the period. Vanguard Group Inc. grew its stake in Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after purchasing an additional 61,400 shares during the period. Clearbridge Investments LLC raised its holdings in Surgery Partners by 1.3% in the second quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company’s stock worth $132,880,000 after purchasing an additional 73,007 shares in the last quarter. Janus Henderson Group PLC raised its holdings in Surgery Partners by 27.5% in the third quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock worth $177,235,000 after purchasing an additional 1,184,450 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C lifted its position in Surgery Partners by 47.7% during the second quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company’s stock valued at $111,986,000 after buying an additional 1,520,484 shares during the period.

Surgery Partners Trading Down 1.5 %

NASDAQ SGRY opened at $23.01 on Tuesday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The stock’s 50-day simple moving average is $29.86 and its two-hundred day simple moving average is $28.35. Surgery Partners has a twelve month low of $21.36 and a twelve month high of $36.92. The company has a market capitalization of $2.92 billion, a price-to-earnings ratio of -47.94, a PEG ratio of 19.44 and a beta of 2.76.

Surgery Partners (NASDAQ:SGRY) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s quarterly revenue was up 14.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.15 earnings per share. Research analysts forecast that Surgery Partners will post 0.73 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.